Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
Expected Frequencies in Goodness-of-Fit Tests01:19

Expected Frequencies in Goodness-of-Fit Tests

A goodness-of-fit test is conducted to determine whether the observed frequency values are statistically similar to the frequencies expected for the dataset. Suppose the expected frequencies for a dataset are equal such as when predicting the frequency of any number appearing when casting a die. In that case, the expected frequency is the ratio of the total number of observations (n) to the number of categories (k).
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
Pharmacodynamic Models: Logarithmic Concentration–Effect Model01:15

Pharmacodynamic Models: Logarithmic Concentration–Effect Model

The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration, limiting its...
Three-Compartment Open Model01:06

Three-Compartment Open Model

The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robust rank-based meta-analyses for two-sample designs with application to platelet counts of malaria infection data.

Statistics in medicine·2023
Same author

Least Squares and Robust Rank-Based Double Bootstrap Analyses for Time-Series Intervention Designs.

Evaluation & the health professions·2022
Same author

Traditional and Rank-Based Tests for Ordered Alternatives in a Cluster Correlated Model.

Psychometrika·2020
Same author

Repeated-measure analyses: Which one? A survey of statistical models and recommendations for reporting.

Neurotoxicology and teratology·2016
Same author

Intimate Partner Violence Associated with Postpartum Depression, Regardless of Socioeconomic Status.

Maternal and child health journal·2016
Same author

Review of rank-based procedures for multicenter clinical trials.

Journal of biopharmaceutical statistics·2013

Related Experiment Video

Updated: May 24, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

Rank-based estimate of four-parameter logistic model.

Kimberly S Crimin1, Joseph W McKean, Thomas J Vidmar

  • 1Biostatistics, Vanderbilt University, Nashville, TN, USA. kimberly.crimin@novartis.com.

Pharmaceutical Statistics
|March 14, 2012
PubMed
Summary

A new robust estimation method using the Wilcoxon norm improves accuracy in calculating the half maximal inhibitory concentration (IC50) during drug development, especially when data contains outliers. This rank-based approach is comparable to traditional methods when data is clean.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

A Tablet-Based Curriculum-Based Measurement Protocol for Kindergarten Writing
15:00

A Tablet-Based Curriculum-Based Measurement Protocol for Kindergarten Writing

Published on: February 7, 2025

Related Experiment Videos

Last Updated: May 24, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

A Tablet-Based Curriculum-Based Measurement Protocol for Kindergarten Writing
15:00

A Tablet-Based Curriculum-Based Measurement Protocol for Kindergarten Writing

Published on: February 7, 2025

Area of Science:

  • Pharmacology
  • Biostatistics
  • Computational Chemistry

Background:

  • Calculating the half maximal inhibitory concentration (IC50) is crucial in drug development, often using a four-parameter logistic model.
  • High-throughput screening generates large datasets where outliers can compromise traditional IC50 estimations.

Purpose of the Study:

  • To introduce a robust, rank-based estimation procedure for the four-parameter logistic model to accurately determine IC50 values.
  • To address the challenge of data outliers in high-throughput drug screening analysis.

Main Methods:

  • A novel rank-based estimation method analogous to least squares, utilizing the Wilcoxon norm, was developed.
  • The proposed robust procedure was applied to pharmaceutical industry data and validated through a simulation study.

Main Results:

  • The robust IC50 estimation method demonstrated comparable accuracy to least squares estimates in the absence of outliers.
  • The rank-based method provided more accurate IC50 values when outliers were present in the response data.
  • A robust goodness-of-fit test was also developed and proposed.

Conclusions:

  • The proposed rank-based estimation method offers a more accurate and reliable approach for IC50 calculation in drug development, particularly in the presence of outliers.
  • This robust statistical technique enhances the quality of data analysis in high-throughput screening, leading to more dependable drug efficacy assessments.